The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Global Prevalence & Burden of Musculoskeletal Disorders

Global Prevalence & Burden of Musculoskeletal Disorders

March 31, 2021 • By Arthritis & Rheumatology

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Introduction & Objectives
Populations around the world are rapidly aging, and good musculoskeletal health is needed for people to have economic, social, and functional independence throughout their life course. But the importance of musculoskeletal disorders is often underappreciated.

You Might Also Like
  • 2015 ACR/ARHP Annual Meeting: Global Challenges in Rheumatic Disease Care
  • Contemporary Prevalence of Gout & Hyperuricemia in the U.S.
  • Lupus Incidence, Prevalence Differ by Race

The burden from musculoskeletal disorders is greatest among aging populations, with resultant enormous costs to the economy and the healthcare system.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Safiri et al. set out to provide a global overview of this burden, reporting the levels and trends of prevalence, deaths and disability-adjusted life years (DALYs) due to musculoskeletal disorders—categorized as low back pain, neck pain, osteoarthritis (OA), rheumatoid arthritis (RA), gout and other musculoskeletal disorders—according to age, sex and sociodemographic factors.

Methods
Data were obtained from the Global Burden of Disease (GBD) Study 2017. The fatal and nonfatal burdens of musculoskeletal disorders were estimated using the Cause of Death Ensemble model and Bayesian metaregression tool, respectively. Estimates were provided for all musculoskeletal disorders and the corresponding six categories at global, regional and national levels from 1990 to 2017. Counts and age-standardized rates per 100,000 population along with 95% uncertainty intervals (95% UIs) were reported for prevalence, deaths and DALYs.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Results
In 2017, approximately 1.3 billion people around the world had a musculoskeletal disorder, and 121.3 thousand deaths and 138.7 million DALYs could be attributed to musculoskeletal disorders.

Age-standardized prevalence, death and DALY rates per 100,000 population were 16,276.2 (95% UI 15,495.5, 17,145.8), 1.6 (95% UI 1.4, 1.6) and 1,720 (95% UI 1,264.4, 2,259.2), respectively. Age-standardized prevalence (−1.6% [95% UI −2.4, −0.8]) and DALY rates (−3.5% [95% UI −4.7, −2.3]) decreased slightly from 1990. The global point prevalence rate of musculoskeletal disorders in 2017 was higher in women than in men and increased with age up to the oldest age group.

Globally, the proportion of prevalent cases according to category of musculoskeletal disorders in 2017 was greatest for low back pain (36.8%), followed by other musculoskeletal disorders (21.5%), OA (19.3%), neck pain (18.4%), gout (2.6%) and RA (1.3%). These proportions did not change appreciably compared with 1990.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

The burden due to musculoskeletal conditions was higher in developed countries. The countries with the highest age-standardized prevalence rates of musculoskeletal disorders in 2017 were Switzerland (23,346.0 [95% UI 22,392.6, 24,329.8]), Chile (23,007.9 [95% UI 21,746.5, 24,165.8]) and Denmark (22,166.1 [95% UI 20,817.2, 23,542.1]). The greatest increases from 1990 were found in Chile (10.8% [95% UI 6.6, 15.4]), Benin (8.8% [95% UI 6.7, 11.1]) and El Salvador (8.5% [95% UI 5.5, 11.9]). 

Pages: 1 2 | Single Page

Filed Under: Conditions Tagged With: Arthritis & Rheumatology, burden, Musculoskeletal, musculoskeletal disease

You Might Also Like:
  • 2015 ACR/ARHP Annual Meeting: Global Challenges in Rheumatic Disease Care
  • Contemporary Prevalence of Gout & Hyperuricemia in the U.S.
  • Lupus Incidence, Prevalence Differ by Race
  • Chronic Opioid Use in Rheumatoid Arthritis: Prevalence & Predictors

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)